Bennett M J, Van Leeuwen J E, Kearse K P
Department of Microbiology & Immunology, East Carolina University, School of Medicine, Greenville, North Carolina 27858-4354, USA.
J Biol Chem. 1998 Sep 11;273(37):23674-80. doi: 10.1074/jbc.273.37.23674.
During T cell development, assembly of the mutisubunit T cell receptor (TCR) complex is regulated by the differential stability of newly synthesized TCRalpha molecules, having a half-life of approximately 20 min in immature CD4+CD8+ thymocytes compared with >75 min in mature T cells. The molecular basis for TCRalpha instability in CD4+CD8+ thymocytes is unknown but has been postulated to involve abnormalities in N-glycan processing and calnexin assembly as perturbation of these pathways markedly destabilizes TCRalpha proteins in all other T cell types examined. Here, we compared the processing of TCRalpha glycoproteins and their assembly with calnexin and calreticulin chaperones in CD4+CD8+ thymocytes and splenic T cells. These studies show that TCRalpha glycoproteins synthesized in CD4+CD8+ thymocytes were processed in a similar manner as those made in splenic T cells and that TCRalpha proteins stably associated with calnexin in both cell types. Interestingly, however, TCRalpha association with the calnexin-related molecule calreticulin was decreased in CD4+CD8+ thymocytes compared with splenic T cells. Finally, TCRalpha degradation in CD4+CD8+ thymocytes was impaired by inhibitors of proteasome activity, which was correlated with stabilization of calnexin.TCRalpha complexes. These data demonstrate that calnexin association is not sufficient to protect TCRalpha proteins from rapid degradation in CD4+CD8+ thymocytes, suggesting that additional components of the quality control system of the endoplasmic reticulum operate to ensure the proper folding of nascent TCRalpha glycoproteins.
在T细胞发育过程中,多亚基T细胞受体(TCR)复合物的组装受新合成的TCRα分子不同稳定性的调节,在未成熟的CD4⁺CD8⁺胸腺细胞中,TCRα分子的半衰期约为20分钟,而在成熟T细胞中则大于75分钟。CD4⁺CD8⁺胸腺细胞中TCRα不稳定的分子基础尚不清楚,但据推测可能涉及N-聚糖加工和钙网蛋白组装异常,因为在所有其他检测的T细胞类型中,这些途径的扰动会显著使TCRα蛋白不稳定。在这里,我们比较了CD4⁺CD8⁺胸腺细胞和脾T细胞中TCRα糖蛋白的加工过程以及它们与钙网蛋白和钙连蛋白伴侣的组装。这些研究表明,在CD4⁺CD8⁺胸腺细胞中合成的TCRα糖蛋白的加工方式与在脾T细胞中合成的相似,并且TCRα蛋白在两种细胞类型中都与钙网蛋白稳定结合。然而,有趣的是,与脾T细胞相比,CD4⁺CD8⁺胸腺细胞中TCRα与钙网蛋白相关分子钙连蛋白的结合减少。最后,蛋白酶体活性抑制剂损害了CD4⁺CD8⁺胸腺细胞中TCRα的降解,这与钙网蛋白-TCRα复合物的稳定有关。这些数据表明,在CD4⁺CD8⁺胸腺细胞中,钙网蛋白的结合不足以保护TCRα蛋白免于快速降解,这表明内质网质量控制系统的其他成分发挥作用以确保新生TCRα糖蛋白的正确折叠。